Please login to the form below

Intarcia

This page shows the latest Intarcia news and features for those working in and with pharma, biotech and healthcare.

Intarcia's diabetes implant beats Merck's Januvia in trial

New injection-less therapy could revolutionise diabetes treatment. Biopharmaceutical company Intarcia Therapeutics' novel sub-dermal pump ITCA 650 has significantly outperformed Januvia in phase III trials. . ... Kurt Graves, chairman, president and CEO

Latest news

Servier licenses device that could 'reshape' diabetes care

Tiny pump implant to deliver GLP-1 agonist. Intarcia's ITCA 650 pump implant is the size of a matchstick. ... Intarcia retains rights to the implant in the US and says it is in the process of seeking a licensee in Japan.
HCV hope on the horizon

and interferon ω (Intarcia Therapeutics).

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest appointments

Dr Sunita Zalani joins Intarcia Therapeutics as regulatory head

Moves to the Boston company from Onyx Pharmaceuticals. Boston-based biopharmaceutical firm Intarcia Therapeutics has appointed Dr Sunita Zalani as vice president, global head of regulatory affairs and quality. ... He said: "We led a very competitive

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Events Executive: DOE

Account Manager – Healthcare advertising: Salary TBC

Strategic Planner, Healthcare Advertising Agency: Salary TBC

Client Services Director- Flexible Working: Negotiable

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Account Director – UK Office: Excellent salary and benefits

Senior Medical Writer: Competitive salary plus benefits

Subscribe to our email news alerts

PMHub

Add my company

Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Report: Customer experience, shaping digital healthcare: In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Encouraging signs in biomarker R&D: The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it: What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...